177. Clinical Outcomes of Daptomycin vs. Anti-Staphylococcal β-Lactams in Definitive Treatment of Methicillin-Susceptible Staphylococcus aureus (MSSA) Bloodstream Infections

BACKGROUND: The preferred management of patients with MSSA bacteremia includes definitive therapy with intravenous anti-staphylococcal β-lactam antibiotics. In β-lactam allergic or intolerant patients, daptomycin has been targeted as a viable alternative. The objective of this study was to assess cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Agnello, Sydney, Day, Shandra R, Wardlow, Lynn, Reed, Erica E, Smith, Jessica M, Stevenson, Kurt, Coe, Kelci E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809556/
http://dx.doi.org/10.1093/ofid/ofz360.252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809556/
http://dx.doi.org/10.1093/ofid/ofz360.252

Ejemplares similares